Potentiation of radiotherapy by a localized antiangiogenic gene therapy

Radiotherapy and Oncology

Volumn 107, Issue 2, 2013, Pages 252-258

  Crokart, Nathalie ^a   Danhier, Fabienne ^a   Daugimont, Liévin ^a   Gonçalves, Nelio ^a   Jordan, Bénédicte F ^a   Grégoire, Vincent ^a   Feron, Olivier ^a   Bouquet, Céline ^b   Gallez, Bernard ^a   Préat, Véronique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b Bioalliance   (France)

Author keywords

Antiangiogenesis; Cancer; Electrotransfer; Gene therapy; Radiosensitization; Tumor microenvironment

Indexed keywords

ANTINEOPLASTIC AGENT; RECOMBINANT DISINTEGRIN DOMAIN OF ADAM 15; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC GENE THERAPY; ARTICLE; CANCER RADIOTHERAPY; CELL VIABILITY; DRUG EFFICACY; ELECTRON SPIN RESONANCE; ELECTROPORATION; FIBROSARCOMA; IN VITRO STUDY; LIVER TUMOR; MALE; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RADIOSENSITIZATION; TISSUE PRESSURE; TUMOR MICROENVIRONMENT;

ADAM PROTEINS; ANGIOGENESIS INHIBITORS; ANIMALS; GENETIC THERAPY; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C3H; RADIATION TOLERANCE; TUMOR MICROENVIRONMENT;

EID: 84879019526     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.03.018     Document Type: Article

References (41)

1. J. Folkman Tumor angiogenesis: therapeutic implications N Engl J Med 285 1971 1182 1186
2. F.A. Scappaticci Mechanisms and future directions for angiogenesis-based cancer therapies J Clin Oncol 20 2002 3906 3927
3. P. Saharinen, L. Eklund, K. Pulkki, P. Bono, and K. Alitalo VEGF and angiopoietin signaling in tumor angiogenesis and metastasis Trends Mol Med 17 2011 347 362
4. S.M. Weis, and D.A. Cheresh Tumor angiogenesis: molecular pathways and therapeutic targets Nat Med 17 2011 1359 1370
5. L. Persano, M. Crescenzi, and S. Indraccolo Anti-angiogenic gene therapy of cancer: current status and future prospects Mol Aspects Med 28 2007 87 114
6. A. Tandle, D.G. Blazer III, and S.K. Libutti Antiangiogenic gene therapy of cancer: recent developments J Transl Med 2 2004 22
7. C Liu, and N. Zhang Emerging biotechnological strategies for non-viral antiangiogenic gene therapy Angiogenesis 15 2012 521 542
8. H.H. Sedlacek Pharmacological aspects of targeting cancer gene therapy to endothelial cells Crit Rev Oncol Hematol 37 2001 169 215 (Pubitemid 32193006)
9. C.C. Liu, Z. Shen, H.F. Kung, and M.C. Lin Cancer gene therapy targeting angiogenesis: an updated review World J Gastroenterol 12 2006 6941 6948 (Pubitemid 44834883)
10. J. Gehl Electroporation for drug and gene delivery in the clinic: doctors go electric Methods Mol Biol 423 2008 351 359
11. L.M. Mir Therapeutic perspectives of in vivo cell electropermeabilization Bioelectrochemistry 53 2001 1 10 (Pubitemid 32015625)
12. M. Cemazar, M. Golzio, G. Sersa, M.P. Rols, and J. Teissie Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand? Curr Pharm Des 12 2006 3817 3825 (Pubitemid 44560715)
13. G. Sersa, D. Miklavcic, M. Cemazar, Z. Rudolf, G. Pucihar, and M. Snoj Electrochemotherapy in treatment of tumours Eur J Surg Oncol 34 2008 232 240
14. K. Kessenbrock, V. Plaks, and Z. Werb Matrix metalloproteinases: regulators of the tumor microenvironment Cell 141 2010 52 67
15. S. Mochizuki, and Y. Okada ADAMs in cancer cell proliferation and progression Cancer Sci 98 2007 621 628 (Pubitemid 46563436)
16. G. Murphy The ADAMs: signalling scissors in the tumour microenvironment Nat Rev Cancer 8 2008 929 941
17. V. Trochon, D. Martel-Renoir, and L.M. Mir Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin Cancer Res 64 2004 2062 2069 (Pubitemid 38339454)
18. L. Daugimont, G. Vandermeulen, and F. Defresne Antitumoral and antimetastatic effect of antiangiogenic plasmids in B16 melanoma: higher efficiency of the recombinant disintegrin domain of ADAM 15 Eur J Pharm Biopharm 78 2011 314 319
19. I. Spanggaard, M. Snoj, and A. Cavalcanti Proof of concept of gene therapy using plasmid AMED in disseminated melanoma: safety and efficacy results of a phase I first-in-man study 1139 Eur Soc Med Oncol Congr 2012
20. R. Ansiaux, C. Baudelet, and B.F. Jordan Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment Clin Cancer Res 11 2005 743 750 (Pubitemid 40116903)
21. D.H. Gorski, H.J. Mauceri, and R.M. Salloum Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin Cancer Res 58 1998 5686 5689 (Pubitemid 29006406)
22. Z. Liao, R. Komaki, K.A. Mason, and L. Milas Role of cyclooxygenase-2 inhibitors in combination with radiation therapy in lung cancer Clin Lung Cancer 4 2003 356 365 (Pubitemid 36798558)
23. M.R. Horsman, and D.W. Siemann Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies Cancer Res 66 2006 11520 11539 (Pubitemid 46094158)
24. R.K. Jain Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy Nat Med 7 2001 987 989 (Pubitemid 32937367)
25. R.K. Jain Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 307 2005 58 62 (Pubitemid 40093472)
26. S. Matsumoto, S. Batra, and K. Saito Antiangiogenic agent sunitinib transiently increases tumor oxygenation and suppresses cycling hypoxia Cancer Res 71 2011 6350 6359
27. J. Segers, F.V. Di, and R. Ansiaux Potentiation of cyclophosphamide chemotherapy using the anti-angiogenic drug thalidomide: importance of optimal scheduling to exploit the normalization window of the tumor vasculature Cancer Lett 244 2006 129 135 (Pubitemid 44485872)
28. R. Ansiaux, C. Baudelet, and B.F. Jordan Mechanism of reoxygenation after antiangiogenic therapy using SU5416 and its importance for guiding combined antitumor therapy Cancer Res 66 2006 9698 9704 (Pubitemid 44623670)
29. R. Ansiaux, J. DeWever, V. Gregoire, O. Feron, B.F. Jordan, and B. Gallez Decrease in tumor cell oxygen consumption after treatment with vandetanib (ZACTIMA; ZD6474) and its effect on response to radiotherapy Radiat Res 172 2009 584 591
30. F. Danhier, P. Danhier, and N. Magotteaux Electron paramagnetic resonance highlights that the oxygen effect contributes to the radiosensitizing effect of paclitaxel PLoS One 7 2012 e40772
31. B. Gallez, B.F. Jordan, C. Baudelet, and P.D. Misson Pharmacological modifications of the partial pressure of oxygen in murine tumors: evaluation using in vivo EPR oximetry Magn Reson Med 42 1999 627 630 (Pubitemid 29468290)
32. P. Sonveaux, C. Dessy, and A. Brouet Modulation of the tumor vasculature functionality by ionizing radiation accounts for tumor radiosensitization and promotes gene delivery FASEB J 16 2002 1979 1981
33. G. Sersa, M. Cemazar, D. Miklavcic, and D.J. Chaplin Tumor blood flow modifying effect of electrochemotherapy with bleomycin Anticancer Res 19 1999 4017 4022
34. Y. Boucher, J.M. Kirkwood, D. Opacic, M. Desantis, and R.K. Jain Interstitial hypertension in superficial metastatic melanomas in humans Cancer Res 51 1991 6691 6694
35. M. Golzio, J. Teissie, and M.P. Rols Cell synchronization effect on mammalian cell permeabilization and gene delivery by electric field Biochim Biophys Acta 1563 2002 23 28 (Pubitemid 34455039)
36. B.F. Jordan, V. Gregoire, and R.J. Demeure Insulin increases the sensitivity of tumors to irradiation: involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consumption Cancer Res 62 2002 3555 3561 (Pubitemid 34651408)
37. T. Jarm, M. Cemazar, F. Steinberg, C. Streffer, G. Sersa, and D. Miklavcic Perturbation of blood flow as a mechanism of anti-tumour action of direct current electrotherapy Physiol Meas 24 2003 75 90 (Pubitemid 36330457)
38. C. Ling, Y. Xie, D. Zhao, Y. Zhu, J. Xiang, and J. Yang Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy Cancer Gene Ther 19 2012 697 706
39. L.L. Liu, M.J. Smith, B.S. Sun, G.J. Wang, H.P. Redmond, and J.H. Wang Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model Ann Surg Oncol 16 2009 1403 1411
40. E.T. Shinohara, and A. Maity Increasing sensitivity to radiotherapy and chemotherapy by using novel biological agents that alter the tumor microenvironment Curr Mol Med 9 2009 1034 1045
41. Y. Zhang, W. Qiu, J. Liang, Z. Yu, and L. Yue Anti-tumor effects of pEgr-1-endostatin-TNF-alpha recombinant plasmid expression induced by ionizing radiation Asian Pac J Cancer Prev 12 2011 2933 2937